Patent intelligence · US
US 10472381
Sialic acid derivatives
Sialic acid derivatives
Patent details — US 10472381
- Jurisdiction
- US
- Status
- granted
- Grant date
- Nov 12, 2019
- Expiration
- Nov 7, 2039
- Applicant
- Reinhard Brossmer
- Claims
- 17
- CPC classes
- A61K, A61K31/7028, A61P, A61P29/00
Quick answer
US 10472381 (Sialic acid derivatives) is held by Reinhard Brossmer. Status: granted. Granted Nov 12, 2019. Expires Nov 7, 2039 (13 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Reinhard Brossmer
- Grant date
- Expiration
- Claims
- 17
- CPC classes
- A61K, A61K31/7028, A61P, A61P29/00, A61P31/04, A61P37/08
More from Reinhard Brossmer
Related pharmaceutical patents in our USPTO index.
-
US 12390512
Depolymerase capable of degrading extracellular polymeric substances of Klebsiella pneumoniae
granted -
US 11033623
Magnetic stem cell therapy for lesions
granted -
US 10265396
Magnetic extracellular matrix
granted -
US 9539228
Composition containing lysine as a nutritional supplement or treatment in the case of herpes
granted -
US 8309071
Foamy viral envelope genes
granted -
US 8293803
Retinoid compounds and their use
granted -
US 8268792
Use of an active ingredient combination that contains hydroxystilbene for preventing and/or treating diseases
granted
Frequently asked questions
What is US patent 10472381?
US 10472381 (Sialic acid derivatives) is held by Reinhard Brossmer. Status: granted. Granted Nov 12, 2019. Expires Nov 7, 2039 (13 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 10472381?
Reinhard Brossmer is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 11 pharmaceutical patents for this assignee.
When does US 10472381 expire?
Our index shows an expiration date of Nov 7, 2039 (13 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.